Abstract
OBJECTIVE: We describe the pharmacological properties of a novel spermine-cholesterol adduct, MSI 1436 (3β-N-1(spermine)-7α, 24R-dihydroxy-5α-cholestane 24-sulfate), which causes reversible suppression of food and fluid intake in mammals resulting in profound weight loss, not associated with other signs or symptoms of illness, and which exhibits antidiabetic properties in genetically obese mice.
METHODS: Wild-type rodents and strains with genetic obesity were studied. Effects on food and fluid intake, body weight and composition were examined along with pharmacological and toxicological parameters.
RESULTS: MSI-1436 induces profound inhibition of food and fluid intake in rats and mice, resulting in significant weight loss. MSI-1436 is active when introduced directly into the third ventricle of the rat, suggesting the compound acts on central targets. Pair-feeding studies suggest that MSI-1436 causes weight loss by suppressing food intake. Fluid intake is also profoundly reduced but animals remain normally hydrated and defend both water and electrolyte balance from parenteral administration. MSI-1436 is active in ob/ob, db/db, agouti and MC4 receptor knockout mice. MSI-1436 has been administered to ob/ob mice over a 4 month period via a regimen that safely controls body weight, glucose homeostasis and serum cholesterol levels. Following MSI-1436 treatment, db/db mice preferentially mobilize adipose tissue and hyperglycemia is corrected.
CONCLUSION: A naturally occurring spermine metabolite of cholesterol, isolated from the dogfish shark, Squalus acanthias, has been identified that induces profound reduction in food and fluid intake in rodents in a setting where thirst is preserved and fluid and electrolyte homeostasis appears to be functioning normally. MSI-1436 probably acts on a central target involving neural circuits that lie downstream from the leptin and the MC4 receptors. Although long-term administration can be accomplished safely in mice, the utility of this compound as a potential human therapeutic awaits an analysis of its pharmacological properties in man.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Moore KS, Wehrli S, Roder H, Rogers M, Forrest JN, McCrimmon D, Zasloff M . Squalamine: an aminosterol antibiotic from the shark Proc Natl Acad Sci USA 1993 90: 1354–1358.
Rao MN, Shinnar AE, Noecker LA, Chao TL, Feibush B, Snyder B, Sharkansky I, Sarkanian A, Zhang X, Jones SR, Kinney WA, Zasloff M . Aminosterols from the dogfish shark Squalus acanthias J Nat Prod 2000 63: 631–635.
Kinter AL, Hardy EC, Williams J, Kinney WA, Chao T, Zasloff M, Fauci AS . MSI-1436, a novel aminosterol, inhibits HIV replication in in vitro and in vivo infected mononuclear cells Presented at the 4th Conference on Retroviruses and Opportunistic Infections Washington, DC 1997.
Alper SL, Chernova MN, Williams J, Zasloff M, Law F-Y, Knaupf PA . Differential inhibition of AE-1 and AE-2 anion exchangers by oxyonol dyes and by novel polyaminosterol analogs of the shark antibiotic squalamine Biochem Cell Biol 1998 76: 799–806.
Akhter S, Nath SK, Tse CM, Williams J, Zasloff M, Donowitz M . Squalamine, a novel cationic steroid, specifically inhibits the brush border Na+/H+ exchanger isoform NHE3 Am J Physiol 1999 276 (Cell Physiol 45): C136–C144.
Zhang X, Rao M, Jones SR, Shao B, Feibush P, McGuigan M, Tzodikov N, Feibush B, Sharkansky I, Snyder B, Mallis L, Sarkanian A, Wilder S, Turse JE, Kinney WA, Jaersgaard HJ, Michalak RS . Synthesis of squalamine utilizing a readily accessible spermidine equivalent J Org Chem 1998 63: 8599–8603.
Jones SR, Selinsky BS, Rao MN, Zhang X, Tham FS . Efficient route to 7-alpha (benzoyloxy)-3-dioxolane cholestane-24(R)-ol, a key intermediate in the synthesis of squalamine J Org Chem 1998 63: 3786–3789.
Woods SC, Seeley RJ, Porte D and Schwartz MH . Signals that regulate food intake and energy homeostasis Science 1998 280: 1378–1383.
Pellymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F . Effects of the obese gene product on body weight regulation in ob/ob mice Science 1995 269: 540–543.
Halaas JL, Gajiwala KS, Maffei S, Cohen L, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM . Weight reducing effects of the plasma protein encoded by the obese gene Science 1995 269: 543–546.
Chen G, Koyama K, Yuan X, Lee Y, Zhou Y-T, O'Doherty R, Newgard CB, Unger RH . Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy Proc Natl Acad Sci USA 1996 93: 14795–14799.
Shimabukuro M, Koyama K, Chen G, Wang M-Y, Trieu F, Lee Y, Newgard CB, Unger RH . Direct antidiabetic effect of leptin through triglyceride depletion of tissues Proc Natl Acad Sci USA 1997 94: 4637–4641.
Denton DA, McKinley MJ . Weisinger RS. Hypothalamic integration of body fluid regulation Proc Natl Acad Sci USA 1996 93: 7397–7404.
Flier JS, Maratos-Flier E . Obesity and the hypothalamus: novel peptides for new pathways Cell 1998 92: 437–440.
Elias CF, Aschkenasi C, Lee C, Kelley J, Ahima RS, Bjorbaek C, Flier JS, Sape CB, Elmquist JK . Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area Neuron 1999 23: 775–786.
Gumbiner B . The treatment of obesity in type 2 diabetes Diabetes 1999 26: 869–883.
Acknowledgements
We wish to thank Miklos Gellai for his encouragement and insightful discussions regarding the physiology of the rat; Tessa Chao, Anne Shinnar, Benny Feibush and Ilya Sharkansky (Magainin Pharmaceuticals) for help in the isolation of MSI-1436 from dogfish liver during early phases of this work; Xuehi Zhang, Meena Rao and Penina Feibush (Magainin Pharmaceuticals) for help in the synthesis of MSI-1436 and its analogs; Keith Yagaloff (Roche Pharmaceuticals) for evaluating MSI-1436 in the MC-4 knockout mouse strain; Yaniv Tomer, Andrew Pastuszak, Veronica Ferrante, Christine Weiss (Magainin Pharmaceuticals) for their assistance in the animal experiments described; Howard Hait for statistical analysis; Jamila Louahed and Lee Maloy for critical reading of the manuscript; and Barbara Zasloff for many helpful discussions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zasloff, M., Williams, J., Chen, Q. et al. A spermine-coupled cholesterol metabolite from the shark with potent appetite suppressant and antidiabetic properties. Int J Obes 25, 689–697 (2001). https://doi.org/10.1038/sj.ijo.0801599
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801599
Keywords
This article is cited by
-
Trodusquemine: Potential Utility in Wound Regeneration
Regenerative Engineering and Translational Medicine (2022)
-
Activation of tyrosine phosphatase PTP1B in pyramidal neurons impairs endocannabinoid signaling by tyrosine receptor kinase trkB and causes schizophrenia-like behaviors in mice
Neuropsychopharmacology (2020)
-
Inhibition of PTP1B by farnesylated 2-arylbenzofurans isolated from Morus alba root bark: unraveling the mechanism of inhibition based on in vitro and in silico studies
Archives of Pharmacal Research (2020)
-
Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes
Nature Communications (2019)
-
The cellular and molecular bases of leptin and ghrelin resistance in obesity
Nature Reviews Endocrinology (2017)